Phillips G B, Morgan T K, Nickisch K, Lind J M, Gomez R P, Wohl R A, Argentieri T M, Sullivan M E
Department of Medicinal Chemistry, Berlex Laboratories, Inc., Cedar Knolls, New Jersey 07927.
J Med Chem. 1990 Feb;33(2):627-33. doi: 10.1021/jm00164a025.
Twelve novel derivatives of the selective class III antiarrhythmic agent sematilide were prepared in an attempt to incorporate both class I and class III electrophysiological properties into a single molecule. Electrophysiological activity was determined by standard microelectrode techniques in canine cardiac Purkinje fibers. Initial assessment of class I efficacy was carried out in a ouabain-induced arrhythmia model in guinea pigs. All of the compounds prolonged action potential duration in Purkinje fibers (class III activity), and three were active against ouabain-induced arrhythmias (class I activity). Selected compounds were evaluated further in dogs for efficacy against arrhythmias occurring 24 h following coronary ligation (automatic arrhythmias) and induced by using programmed electrical stimulation techniques (reentrant arrhythmias). The most effective compounds from the series are 3g and -j, which were effective in both canine models. Molecular modeling and structure-activity relationships are discussed.
制备了12种新型的选择性III类抗心律失常药物司美利特衍生物,试图将I类和III类电生理特性整合到一个分子中。通过标准微电极技术在犬心脏浦肯野纤维中测定电生理活性。在哇巴因诱导的豚鼠心律失常模型中对I类疗效进行了初步评估。所有化合物均延长了浦肯野纤维的动作电位时程(III类活性),其中三种对哇巴因诱导的心律失常有活性(I类活性)。对选定的化合物在犬中进一步评估其对冠状动脉结扎后24小时发生的心律失常(自律性心律失常)和使用程控电刺激技术诱发的心律失常(折返性心律失常)的疗效。该系列中最有效的化合物是3g和3j,它们在两种犬模型中均有效。讨论了分子建模和构效关系。